EE461 Cost of Biomarker Testing Among Patients with Metastatic Lung or Thyroid Cancer in the US: A Real-World Commercial Claims Database Study

Autor: LM Hess, D Michael, PM Krein, T Marquart, AN Sireci

Publikováno v: Value in Health. 25:S425

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9d643ee385a7dc1307c4c95b2e55a9d
https://doi.org/10.1016/j.jval.2022.04.709

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA.

Autor: Bhandari NR; Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Hess LM; Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285, USA., Parikh RC; RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC 27709, USA., Sireci AN; Loxo Oncology at Lilly, Stamford, CT 06901, USA., Krein PM; Loxo Oncology at Lilly, Stamford, CT 06901, USA., Kaye JA; RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA 02452, USA.

Publikováno v: Personalized medicine [Per Med] 2023 Mar; Vol. 20 (2), pp. 131-142. Date of Electronic Publication: 2023 Feb 07.

Initial versus early switch to targeted therapy during first-line treatment among patients with biomarker-positive advanced or metastatic non-small cell lung cancer in the United States.

Autor: Hess LM; Eli Lilly and Company, Indianapolis, USA. Electronic address: Hess_lisa_m@lilly.com., Peterson P; Eli Lilly and Company, Indianapolis, USA., Sugihara T; Syneos Health, Morrisville USA., Bhandari NR; Eli Lilly and Company, Indianapolis, USA., Krein PM; Loxo@Lilly, Indianapolis USA., Sireci A; Loxo@Lilly, Indianapolis USA.

Publikováno v: Cancer treatment and research communications [Cancer Treat Res Commun] 2023; Vol. 37, pp. 100761. Date of Electronic Publication: 2023 Sep 12.

Enhanced production of IGF-I in the lungs of fibroproliferative ARDS patients.

Autor: Andonegui G; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Immunology Research Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Krein PM; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Immunology Research Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Mowat C; Immunology Research Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Brisebois R; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Department of Surgery, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Doig C; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Department of Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Green FH; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Airway Inflammation Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Léger C; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Immunology Research Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada., Winston BW; Department of Critical Care Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Immunology Research Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Department of Medicine, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Airway Inflammation Group, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary Health Research Innovation Center, Calgary, Alberta, Canada.

Publikováno v: Physiological reports [Physiol Rep] 2014 Nov 03; Vol. 2 (11). Date of Electronic Publication: 2014 Nov 03 (Print Publication: 2014).

Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency.

Autor: Spencer LT; Division of Pulmonary Diseases, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL 32610-0296, USA. spenclt@peds.ufl.edu, Paone G, Krein PM, Rouhani FN, Rivera-Nieves J, Brantly ML

Publikováno v: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2004 Mar; Vol. 286 (3), pp. L514-20. Date of Electronic Publication: 2003 Oct 31.